Drug Shortage Report for ALPHAGAN P

Last updated on 2020-10-24 History
Report ID 124122
Drug Identification Number 02248151
Brand name ALPHAGAN P
Common or Proper name Alphagan P
Company Name ALLERGAN INC
Market Status MARKETED
Active Ingredient(s) BRIMONIDINE TARTRATE
Strength(s) 0.15%
Dosage form(s) SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 5 ml
ATC code S01EA
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2020-09-14
Actual start date 2020-09-17
Estimated end date
Actual end date 2020-10-23
Shortage status Resolved
Updated date 2020-10-24
Company comments
Health Canada comments
Company contact information Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2020-10-24 English Compare
v10 2020-10-23 French Compare
v9 2020-10-23 English Compare
v8 2020-10-07 French Compare
v7 2020-10-07 English Compare
v6 2020-09-18 English Compare
v5 2020-09-17 French Compare
v4 2020-09-17 English Compare
v3 2020-09-15 English Compare
v2 2020-09-11 French Compare
v1 2020-09-11 English Compare